Drugs / Tissucol Duo®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03914963 | Feb 2012 → Jun 2016 | lymphocele | IBON JAUNARENA | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tissucol Duo | “The objective of this study was to assess the efficacy of the Tissucol Duo® (Baxter AG Industriestrasse 67 A-1221 Vienna, Austria) fibrin sealant in decreasing the incidence of...” NCT03914963 ↗ |
| Modality | Protein / enzyme biologic | “Tissucol Duo® (Baxter AG Industriestrasse 67 A-1221 Vienna, Austria) fibrin sealant” NCT03914963 ↗ |
| Route | Topical | “5 ml of sealant was sprayed evenly across the entire surgical bed in only one hemipelvis” NCT03914963 ↗ |